MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 128786 | Name: UMN-627

Description:

WARNING: This product is for research use only, not for human or veterinary use.

UMN-627 is a BET inhibitor.

Chemical Structure

UMN-627
UMN-627
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 128786

Name: UMN-627

CAS#: N/A

Chemical Formula: C29H32F3N7

Exact Mass: 535.2671

Molecular Weight: 535.62

Elemental Analysis: C, 65.03; H, 6.02; F, 10.64; N, 18.31

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BRD4-D1; UMN627; UMN-627
IUPAC/Chemical Name
4-(1-(1-(2-aminoethyl)piperidin-4-yl)-4-(4-(trifluoromethyl)phenyl)-1H-imidazol-5-yl)-N-(3,5-dimethylphenyl)pyrimidin-2-amine
InChi Key
BRLZGRRJGHILMO-UHFFFAOYSA-N
InChi Code
InChI=1S/C29H32F3N7/c1-19-15-20(2)17-23(16-19)36-28-34-11-7-25(37-28)27-26(21-3-5-22(6-4-21)29(30,31)32)35-18-39(27)24-8-12-38(13-9-24)14-10-33/h3-7,11,15-18,24H,8-10,12-14,33H2,1-2H3,(H,34,36,37)
SMILES Code
NCCN(CC1)CCC1N(C=N2)C(C3=CC=NC(NC4=CC(C)=CC(C)=C4)=N3)=C2C5=CC=C(C(F)(F)F)C=C5
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 535.62 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Cui H, Divakaran A, Hoell ZJ, Ellingson MO, Scholtz CR, Zahid H, Johnson JA, Griffith EC, Gee CT, Lee AL, Khanal S, Shi K, Aihara H, Shah VH, Lee RE, Harki DA, Pomerantz WCK. A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes. J Med Chem. 2022 Feb 10;65(3):2342-2360. doi: 10.1021/acs.jmedchem.1c01779. Epub 2022 Jan 10. PMID: 35007061; PMCID: PMC9683399. 2: Cui H, Divakaran A, Pandey AK, Johnson JA, Zahid H, Hoell ZJ, Ellingson MO, Shi K, Aihara H, Harki DA, Pomerantz WCK. Selective N-Terminal BET Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement*. Angew Chem Int Ed Engl. 2021 Jan 18;60(3):1220-1226. doi: 10.1002/anie.202008625. Epub 2020 Nov 18. PMID: 32975004; PMCID: PMC7855888. 3: Cui H, Carlson AS, Schleiff MA, Divakaran A, Johnson JA, Buchholz CR, Zahid H, Vail NR, Shi K, Aihara H, Harki DA, Miller GP, Topczewski JJ, Pomerantz WCK. 4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity. J Med Chem. 2021 Jul 22;64(14):10497-10511. doi: 10.1021/acs.jmedchem.1c00933. Epub 2021 Jul 8. PMID: 34236185; PMCID: PMC8491147. 4: Carlson AS, Cui H, Divakaran A, Johnson JA, Brunner RM, Pomerantz WCK, Topczewski JJ. Systematically Mitigating the p38α Activity of Triazole-based BET Inhibitors. ACS Med Chem Lett. 2019 Aug 2;10(9):1296-1301. doi: 10.1021/acsmedchemlett.9b00227. PMID: 31531200; PMCID: PMC6746085. 5: Doskey LC, Scholtz CR, Vail NR, Khanal S, Lee AL, Kandanur SGS, Hoell ZJ, Huehls AM, Issa MR, Kostallari E, Cao S, Reid JM, Shah VH, Malhi H, Pomerantz WCK. Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease. J Med Chem. 2025 Apr 14. doi: 10.1021/acs.jmedchem.4c02555. Epub ahead of print. PMID: 40227166.